id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-V-0897-0003,FDA,FDA-2011-V-0897,FDA/CDRH to NLFX Professional - Approval for Variance,Other,Approval for Variance (VRA),2012-09-19T04:00:00Z,2012,9,2012-09-19T04:00:00Z,,2012-09-19T15:40:09Z,,0,0,090000648111dbe2
FDA-2011-V-0897-0002,FDA,FDA-2011-V-0897,Acknowledgement Letter to NLFX Professional,Other,Acknowledgement Letter/Receipt,2011-12-22T05:00:00Z,2011,12,2011-12-22T05:00:00Z,,2011-12-22T17:27:57Z,,0,0,0900006480f80657
FDA-2011-V-0897-0001,FDA,FDA-2011-V-0897,NLFX Professional - Application for Variance,Other,Application for Variance (VAR),2011-12-22T05:00:00Z,2011,12,2011-12-22T05:00:00Z,,2011-12-22T17:27:57Z,,0,0,0900006480f80602